Greetings,
this is the official announce for the next meeting of the MSLUG.
What: Montreal Scheme/Lisp User Group Meeting Where: Room 3195, André-Aisenstadt Building, Université de Montréal, 2920 chemin de la Tour (you can find a plan of the UdeM campus here: http://www.stcum.qc.ca/metro/images/c56.pdf) When: December 5th 2007 at 7pm
We will have the chance to hear 4 different talks, of around 15 to 20 minutes each, about using Scheme and Lisp in a commercial setting. After the talks, those of us who feel so inclined will go down to a nearby pub to have a beer and continue the discussion.
The meeting is open to everyone, feel free to invite friends and co-workers!
See you next Wednesday,
Guillaume
* Talks Program *
1- Houman Zolfaghari : Using scheme in the industry: a possibly powerful but difficult choice
Having used scheme/lisp for more than 12 years in the industry for some large scale projects, I will talk a bout my experience and my latest considerations and conclusions.
----------
2- Dominique Boucher : Scheme in the enterprise: pitfalls to avoid
In this short presentation, I will share my experience introducing Scheme in an industrial setting. I will mainly focus on how to avoid some common pitfalls.
----------
3- Daniel Villeneuve & Alain Marcotte : Three goals, 2 companies, 1 ...
Overview of 3 utilizations of scheme in two different companies where scheme is part of delivered products. A glance at the architecture and environment for those products.
Survol de 3 utilisations de scheme à travers 2 entreprises: Micro-Intel (Cogniscience) et ADOPT (Kronos). Survol de l'environnement et architecture où scheme fait partie des produits livrés.
----------
4- Guillaume Cartier :
Overview of the Chyma Scheduler, a rule-based scheduler for hospitals written for IsaiX Technologies using JazzScheme under its new open source license.
I will also discuss how it has been possible for us on various occasions to help clients with Lisp based solutions when the hurt was considerable and Lisp was seen as the only doctor with potent enough medicine.